Hemoglobin Completed Phase 3 Trials for Systemic Inflammatory Response Syndrome (SIRS) / Shock Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00021502Safety and Efficacy of PHP in the Treatment of Shock Associated With Systemic Inflammatory Response Syndrome (SIRS)